{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T14:01:29Z","timestamp":1784988089058,"version":"3.55.0"},"reference-count":47,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015685","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T10:30:35Z","timestamp":1718015435000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anticoagulation during extracorporeal membrane oxygenation"],"prefix":"10.1002","volume":"2024","author":[{"given":"Troy","family":"Seelhammer","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology; Mayo Clinic; Rochester MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Ninan","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Critical Care; MultiCare Capital Medical Center; Olympia WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Nei","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Mayo Clinic; Rochester MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph GS","family":"Nabzdyk","sequence":"additional","affiliation":[{"name":"Department of Critical Care and Anesthesia; Mass General Brigham; Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Health Services Research; Mayo Clinic; Rochester MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Gerberi","sequence":"additional","affiliation":[{"name":"Mayo Medical Libraries; Mayo Clinic; Rochester MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M","family":"Wieruszewski","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology; Mayo Clinic; Rochester MN USA"},{"name":"Department of Pharmacy; Mayo Clinic; Rochester MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD015685-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/MAT.0000000000001004","article-title":"Evaluation of anti-xa and activated partial thromboplastin time monitoring of heparin in adult patients receiving extracorporeal membrane oxygenation support","volume":"66","author":"Arnouk","year":"2020","journal-title":"ASAIO Journal"},{"key":"10.1002\/14651858.CD015685-BIB0002|cit2","unstructured":"Covidence Veritas Health Innovation"},{"issue":"2","key":"10.1002\/14651858.CD015685-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/PCC.0000000000000317","article-title":"Association of bleeding and thrombosis with outcome in extracorporeal life support","volume":"16","author":"Dalton","year":"2015","journal-title":"Pediatric Critical Care Medicine"},{"key":"10.1002\/14651858.CD015685-BIB0004|cit4","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015685-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fmed.2018.00352","article-title":"Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components","volume":"5","author":"Doyle","year":"2018","journal-title":"Frontiers in Medicine (Lausanne)"},{"key":"10.1002\/14651858.CD015685-BIB0006|cit6","unstructured":"ELSO Registry Data Definitions. ELSO, 2024 new registry elso registry data definitions 2024.pdf"},{"issue":"4","key":"10.1002\/14651858.CD015685-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD015685-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/PCC.0000000000002384","article-title":"Evaluation of bivalirudin as an alternative to heparin for systemic anticoagulation in pediatric extracorporeal membrane oxygenation","volume":"21","author":"Hamzah","year":"2020","journal-title":"Pediatric Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015685-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"L12","DOI":"10.1152\/ajplung.00304.2020","article-title":"Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19","volume":"320","author":"Hanidziar","year":"2021","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"4","key":"10.1002\/14651858.CD015685-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/MAT.0000000000001814","article-title":"Comparison of bivalirudin versus heparin for anticoagulation during extracorporeal membrane oxygenation","volume":"69","author":"Hasegawa","year":"2023","journal-title":"ASAIO Journal"},{"key":"10.1002\/14651858.CD015685-BIB0011|cit11","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015685-BIB0012|cit12","unstructured":"Higgins JP Li T Deeks LJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook"},{"issue":"12","key":"10.1002\/14651858.CD015685-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"e1252","DOI":"10.1097\/CCM.0000000000005110","article-title":"A core outcome set for research in patients on extracorporeal membrane oxygenation","volume":"49","author":"Hodgson","year":"2021","journal-title":"Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015685-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.21037\/acs.2018.07.03","article-title":"Traditional and non-traditional anticoagulation management during extracorporeal membrane oxygenation","volume":"8","author":"Koster","year":"2019","journal-title":"Annals of Cardiothoracic Surgery"},{"key":"10.1002\/14651858.CD015685-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.thromres.2021.12.024","article-title":"Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis","volume":"210","author":"Li","year":"2022","journal-title":"Thrombosis Research"},{"issue":"508","key":"10.1002\/14651858.CD015685-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1080\/01621459.2014.946318","article-title":"Exact meta-analysis approach for discrete data and its application to 2 \u00d7 2 tables with rare events","volume":"109","author":"Liu","year":"2014","journal-title":"Journal of the American Statistical Association"},{"issue":"4","key":"10.1002\/14651858.CD015685-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"e0249854","DOI":"10.1371\/journal.pone.0249854","article-title":"Low vs standardized dose anticoagulation regimens for extracorporeal membrane oxygenation: a meta-analysis","volume":"16","author":"Lv","year":"2021","journal-title":"PLOS One"},{"issue":"6","key":"10.1002\/14651858.CD015685-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/MAT.0000000000001291","article-title":"Bivalirudin may reduce the need for red blood cell transfusion in pediatric cardiac patients on extracorporeal membrane oxygenation","volume":"67","author":"Machado","year":"2021","journal-title":"ASAIO Journal"},{"issue":"8","key":"10.1002\/14651858.CD015685-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00134-022-06794-y","article-title":"Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study","volume":"48","author":"Mansour","year":"2022","journal-title":"Intensive Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD015685-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1213\/ANE.0000000000004275","article-title":"Coagulation factor levels and underlying thrombin generation patterns in adult extracorporeal membrane oxygenation patients","volume":"129","author":"Mazzeffi","year":"2019","journal-title":"Anesthesia & Analgesia"},{"issue":"3","key":"10.1002\/14651858.CD015685-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/02676591221150880","article-title":"Outcomes of heparinized adult veno-arterial extracorporeal membrane oxygenation patients managed with low and high activated partial thromboplastin time targets: a systematic review and meta-analysis","volume":"39","author":"Mazzeffi","year":"2024","journal-title":"Perfusion"},{"issue":"3","key":"10.1002\/14651858.CD015685-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/mat.0000000000000986","article-title":"Correlation among antifactor xa, activated partial thromboplastin time, and heparin dose and association with pediatric extracorporeal membrane oxygenation complications","volume":"66","author":"McMichael","year":"2020","journal-title":"ASAIO Journal"},{"issue":"3","key":"10.1002\/14651858.CD015685-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1051\/ject\/201850161","article-title":"Bivalirudin anticoagulation dosing protocol for extracorporeal membrane oxygenation: a retrospective review","volume":"50","author":"Netley","year":"2018","journal-title":"Journal of ExtraCorporeal Technology"},{"issue":"3","key":"10.1002\/14651858.CD015685-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/MAT.0000000000000811","article-title":"Impact of anticoagulation and circuit technology on complications during extracorporeal membrane oxygenation","volume":"65","author":"Niebler","year":"2019","journal-title":"ASAIO Journal"},{"issue":"3","key":"10.1002\/14651858.CD015685-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/MAT.0000000000001230","article-title":"Thrombosis and bleeding in extracorporeal membrane oxygenation (ECMO) without anticoagulation: a systematic review","volume":"67","author":"Olson","year":"2021","journal-title":"ASAIO Journal"},{"issue":"1","key":"10.1002\/14651858.CD015685-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1053\/j.jvca.2012.07.019","article-title":"Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study","volume":"27","author":"Pieri","year":"2013","journal-title":"Journal of Cardiothoracic and Vascular Anesthesia"},{"issue":"2","key":"10.1002\/14651858.CD015685-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2450\/2010.0066-10","article-title":"Risk factors for venous and arterial thrombosis","volume":"9","author":"Previtali","year":"2011","journal-title":"Blood Transfusion"},{"key":"10.1002\/14651858.CD015685-BIB0028|cit28","unstructured":"R: A Language and Environment for Statistical Computing R Core Team R Foundation for Statistical Computing, Vienna, Austria 2023"},{"issue":"9","key":"10.1002\/14651858.CD015685-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.3390\/jcm12093224","article-title":"Association of aPTT-guided anticoagulation monitoring with thromboembolic events in patients receiving V-A ECMO support: a systematic review and meta-analysis","volume":"12","author":"Rajsic","year":"2023","journal-title":"Journal of Clinical Medicine"},{"issue":"6","key":"10.1002\/14651858.CD015685-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"R275","DOI":"10.1186\/cc10556","article-title":"Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation","volume":"15","author":"Ranucci","year":"2011","journal-title":"Critical Care"},{"key":"10.1002\/14651858.CD015685-BIB0031|cit31","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"7","key":"10.1002\/14651858.CD015685-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/CCM.0000000000004944","article-title":"Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin","volume":"49","author":"Rivosecchi","year":"2021","journal-title":"Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015685-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.athoracsur.2010.12.064","article-title":"An assay to monitor bivalirudin levels on cardiopulmonary bypass","volume":"92","author":"Salemi","year":"2011","journal-title":"Annals of Thoracic Surgery"},{"issue":"5","key":"10.1002\/14651858.CD015685-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/0885066616656333","article-title":"Bivalirudin for alternative anticoagulation in extracorporeal membrane oxygenation: a systematic review","volume":"32","author":"Sanfilippo","year":"2017","journal-title":"Journal of Intensive Care Medicine"},{"issue":"9","key":"10.1002\/14651858.CD015685-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1097\/CCM.0000000000005033","article-title":"Comparison of bivalirudin versus heparin for maintenance systemic anticoagulation during adult and pediatric extracorporeal membrane oxygenation","volume":"49","author":"Seelhammer","year":"2021","journal-title":"Critical Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD015685-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/MAT.0000000000001598","article-title":"Comparison of bivalirudin versus unfractionated heparin for anticoagulation in adult patients on extracorporeal membrane oxygenation","volume":"68","author":"Sheridan","year":"2022","journal-title":"ASAIO Journal"},{"issue":"4","key":"10.1002\/14651858.CD015685-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/rth2.12346","article-title":"Hematologic concerns in extracorporeal membrane oxygenation","volume":"4","author":"Sniderman","year":"2020","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD015685-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015685-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.hrtlng.2023.05.003","article-title":"Comparison of anticoagulation monitoring strategies for adults supported on extracorporeal membrane oxygenation: a systematic review","volume":"61","author":"Sun","year":"2023","journal-title":"Heart & Lung"},{"issue":"1","key":"10.1002\/14651858.CD015685-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-0037-1606179","article-title":"Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation","volume":"44","author":"Thomas","year":"2018","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"1","key":"10.1002\/14651858.CD015685-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/MAT.0000000000001723","article-title":"Bivalirudin versus unfractionated heparin in patients with cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation","volume":"69","author":"Uricchio","year":"2023","journal-title":"ASAIO Journal"},{"issue":"3","key":"10.1002\/14651858.CD015685-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1055\/s-0036-1597297","article-title":"Laboratory monitoring of parenteral direct thrombin inhibitors","volume":"43","author":"Van Cott","year":"2017","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"2","key":"10.1002\/14651858.CD015685-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/MAT.0000000000000780","article-title":"Bivalirudin dosing requirements in adult patients on extracorporeal life support with or without continuous renal replacement therapy","volume":"65","author":"Walker","year":"2019","journal-title":"ASAIO Journal"},{"key":"10.1002\/14651858.CD015685-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD015685-BIB0045|cit45","unstructured":"WebPlotDigitizer 2022"},{"issue":"6","key":"10.1002\/14651858.CD015685-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"e569","DOI":"10.1097\/CCM.0000000000005466","article-title":"Longitudinal trends in bleeding complications on extracorporeal life support over the past two decades-extracorporeal life support organization registry analysis","volume":"50","author":"Willers","year":"2022","journal-title":"Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015685-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12959-023-00452-z","article-title":"Current and future strategies to monitor and manage coagulation in ECMO patients","volume":"21","author":"Zeibi Shirejini","year":"2023","journal-title":"Thrombosis Journal"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T10:30:44Z","timestamp":1718015444000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015685"}},"subtitle":[],"editor":[{"name":"Cochrane Emergency and Critical Care Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015685","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,10]]}}}